Literature DB >> 30347189

Expression and characterization of soluble epitope-defined major histocompatibility complex (MHC) from stable eukaryotic cell lines.

Amanda L Wooster1, Trevor S Anderson1, Devin B Lowe2.   

Abstract

MHC class I-specific reagents such as fluorescently-labeled multimers (e.g., tetramers) have greatly advanced the understanding of CD8+ T cells under normal and diseased states. However, recombinant MHC class I components (comprising MHC class I heavy chain and β2 microglobulin) are usually produced in bacteria following a lengthy purification protocol that requires additional non-covalent folding steps with exogenous peptide for complete molecular assembly. We have provided an alternative and rapid approach to generating soluble and fully-folded MHC class I molecules in eukaryotic cell lines (such as CHO cells) using a Sleeping Beauty transposon system. Importantly, this method culminates in generating stable cell lines that reliably secrete epitope-defined MHC class I molecules into the tissue media for convenient purification and eventual biotinylation/multimerization. Additionally, MHC class I components are covalently linked, providing the opportunity to produce a diverse set of CD8+ T cell-specific reagents bearing peptides with various affinities to MHC class I.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dextramer; Major histocompatibility complex (MHC) class I; Single-chain trimer; Sleeping beauty transposon system; Stable cell line generation; Tetramer

Mesh:

Substances:

Year:  2018        PMID: 30347189      PMCID: PMC6322931          DOI: 10.1016/j.jim.2018.10.006

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  26 in total

1.  Soluble class I MHC with beta2-microglobulin covalently linked peptides: specific binding to a T cell hybridoma.

Authors:  J White; F Crawford; D Fremont; P Marrack; J Kappler
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

2.  Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes.

Authors:  Tim F Greten; Firouzeh Korangy; Gunnar Neumann; Heiner Wedemeyer; Karola Schlote; Astrid Heller; Stephan Scheffer; Drew M Pardoll; Annette I Garbe; Jonathan P Schneck; Michael P Manns
Journal:  J Immunol Methods       Date:  2002-12-20       Impact factor: 2.303

3.  Structural engineering of pMHC reagents for T cell vaccines and diagnostics.

Authors:  Vesselin Mitaksov; Steven M Truscott; Lonnie Lybarger; Janet M Connolly; Ted H Hansen; Daved H Fremont
Journal:  Chem Biol       Date:  2007-08

Review 4.  Towards personalized, tumour-specific, therapeutic vaccines for cancer.

Authors:  Zhuting Hu; Patrick A Ott; Catherine J Wu
Journal:  Nat Rev Immunol       Date:  2017-12-11       Impact factor: 53.106

Review 5.  Cell Biology of T Cell Receptor Expression and Regulation.

Authors:  Andrés Alcover; Balbino Alarcón; Vincenzo Di Bartolo
Journal:  Annu Rev Immunol       Date:  2017-12-20       Impact factor: 28.527

Review 6.  TCR tuning of T cell subsets.

Authors:  Jae-Ho Cho; Jonathan Sprent
Journal:  Immunol Rev       Date:  2018-05       Impact factor: 12.988

7.  MHC-Peptide Tetramers to Visualize Antigen-Specific T Cells.

Authors:  John D Altman; Mark M Davis
Journal:  Curr Protoc Immunol       Date:  2016-11-01

8.  Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates.

Authors:  Lajos Mátés; Marinee K L Chuah; Eyayu Belay; Boris Jerchow; Namitha Manoj; Abel Acosta-Sanchez; Dawid P Grzela; Andrea Schmitt; Katja Becker; Janka Matrai; Ling Ma; Ermira Samara-Kuko; Conny Gysemans; Diana Pryputniewicz; Csaba Miskey; Bradley Fletcher; Thierry VandenDriessche; Zoltán Ivics; Zsuzsanna Izsvák
Journal:  Nat Genet       Date:  2009-05-03       Impact factor: 38.330

Review 9.  Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation.

Authors:  Marek Wieczorek; Esam T Abualrous; Jana Sticht; Miguel Álvaro-Benito; Sebastian Stolzenberg; Frank Noé; Christian Freund
Journal:  Front Immunol       Date:  2017-03-17       Impact factor: 7.561

10.  CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection.

Authors:  Vishal Khairnar; Vikas Duhan; Ashwini M Patil; Fan Zhou; Hilal Bhat; Christine Thoens; Piyush Sharma; Tom Adomati; Sarah-Kim Friendrich; Judith Bezgovsek; Janine D Dreesen; Gunther Wennemuth; Astrid M Westendorf; Gennadiy Zelinskyy; Ulf Dittmer; Cornelia Hardt; Jörg Timm; Joachim R Göthert; Philipp A Lang; Bernhard B Singer; Karl S Lang
Journal:  Nat Commun       Date:  2018-07-02       Impact factor: 14.919

View more
  2 in total

1.  MHC-I peptide binding activity assessed by exchange after cleavage of peptide covalently linked to β2-microglobulin.

Authors:  Mollie M Jurewicz; Richard A Willis; Vasanthi Ramachandiran; John D Altman; Lawrence J Stern
Journal:  Anal Biochem       Date:  2019-06-13       Impact factor: 3.365

2.  Production of soluble pMHC-I molecules in mammalian cells using the molecular chaperone TAPBPR.

Authors:  Sara M O'Rourke; Giora I Morozov; Jacob T Roberts; Adam W Barb; Nikolaos G Sgourakis
Journal:  Protein Eng Des Sel       Date:  2019-12-31       Impact factor: 1.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.